Annual Meeting: Melanoma Survival Benefit Called 'Astounding'

feeds has 409 videos Subscribe Here

Description: CHICAGO -- Patients with metastatic melanoma had an "astounding" 63% reduction in the risk of death when treated with an investigational agent that targets a mutation found in about half of the tumors, data from a large international trial showed.
Shared By : feeds
Posted on : 06/18/11
Added : 8 years ago